PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$308.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
20 November 2023
Colorectal Cancer: Disease and Advanced Drug Delivery Strategies examines the combined impact of basic clinical and medical treatments as well as recent advances in the field of colorectal cancer. With a strong focus towards colorectal cancer diagnosis, disease drug delivery, and diagnosis, the book also examines the Tumor microenvironment-responsive and site-specific nanoparticles for cancer theragnostics. Sections provide the opportunity to understand and diagnose the disease, describes screening methods, and update on drugs, including nano- and immunotherapy. Content includes clinical trials in colorectal cancer research and disease models that help better direct researchers and clinicians on how to diagnose and treat colorectal cancer.

Edited by:   , , , , , , , , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780443138706
ISBN 10:   0443138702
Pages:   316
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1. Colorectal Cancer: Understanding of disease 2. Impact of the microbiome on colorectal cancer development 3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application 4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis 5. Current drug therapy in Colorectal Cancer 6. Recent advancements in Immunotherapy in colon cancer targeting 7. Novel targeting formulations in Colorectal Cancer 8. Polymeric nanoparticles in Colorectal Cancer 9. Lipid nanoparticles in Colorectal Cancer 10. Micro, nano emulsions in Colorectal Cancer 11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine 12. Bacteriotherapy in Colorectal cancer 13. Biomarker and theranostic in colorectal cancer 14. Advance precision medicine to combat colorectal cancer 15. Recent updates of clinical trials for Colorectal Cancer 16. Disease Models in Colorectal Cancer Research 17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer 18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer 19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance

Dr. Prajapati is a Professor in Department of Pharmaceutics, Shree S.K.Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India. He has more than 20 years of academic and research experience, has published more than 100 research and review papers in international and national Journals. Under his editorial two book under process and he authored 20 book chapters in the field of novel drug delivery. He published two Indian patent and three application under evaluation. He is a reviewer in three high impact journals and is on the editorial board of several scientific journals. Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems. Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.

See Also